Is PCOGF or JNJ a better dividend investment in 2026?

PCOGF currently yields 22598.87% with a 5% 5-year dividend growth rate. JNJ yields 2.14% with 5.8% growth. The better choice depends on your goal: PCOGF offers higher current income.

What is the dividend yield difference between PCOGF and JNJ?

PCOGF has a forward dividend yield of 22598.87% ($2.00/share annually). JNJ yields 2.14% ($5.20/share annually). The yield gap is 22596.73 percentage points.

Home › Compare › PCOGF vs JNJ

PCOGF vs JNJ: Dividend Comparison 2026

PCOGF yields 22598.87% · JNJ yields 2.14%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 PCOGF wins by $176567887962527563776.00M in total portfolio value

INVESTMENT

TIME HORIZON10 years

PCOGF

● Live price

22598.87%

Share price

$0.01

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$176567887962527563776.00M

Annual income

$175,044,190,467,901,770,000,000,000.00

Full PCOGF calculator →

JNJ

Johnson & Johnson

● Live price

2.14%

Share price

$242.49

Annual div

$5.20

5Y div CAGR

28%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$30.5K

Annual income

$4,749.88

Full JNJ calculator →

Portfolio growth — PCOGF vs JNJ

📍 PCOGF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	PCOGF	JNJ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, PCOGF + JNJ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

PCOGF pays

JNJ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PCOGF

Annual income on $10K today (after 15% tax)

$1,920,903.95/yr

After 10yr DRIP, annual income (after tax)

$148,787,561,897,716,500,000,000,000.00/yr

JNJ

Annual income on $10K today (after 15% tax)

$182.28/yr

After 10yr DRIP, annual income (after tax)

$4,037.40/yr

At 15% tax rate, PCOGF beats the other by $148,787,561,897,716,500,000,000,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PCOGF + JNJ for your $10,000?

PCOGF: 50%JNJ: 50%

100% JNJ50/50100% PCOGF

Portfolio after 10yr

$88283943981263781888.00M

Annual income

$87,522,095,233,950,890,000,000,000.00/yr

Blended yield

99.14%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

PCOGF

No analyst data

Altman Z

91.8

Piotroski

2/9

JNJ

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$228.73

-5.7% upside vs current

Range: $190.00 — $265.00

Altman Z

5.2

Piotroski

4/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PCOGF buys

JNJ buys

No recent congressional trades found for PCOGF or JNJ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricPCOGFJNJ

Forward yield	22598.87% ✓	2.14%
Annual dividend / share	$2.00	$5.20 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	28% ✓
Portfolio after 10y	$176567887962527563776.00M ✓	$30.5K
Annual income after 10y	$175,044,190,467,901,770,000,000,000.00 ✓	$4,749.88
Total dividends collected	$176467449724026257408.00M ✓	$15.6K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: PCOGF vs JNJ ($10,000, DRIP)

Year	PCOGF Portfolio	PCOGF Income/yr	JNJ Portfolio	JNJ Income/yr	Gap
1← crossover	$2,270,587	$2,259,887.01	$10,594	$274.49	+$2.26M → PCOGF
2	$481,987,478	$479,557,950.40	$11,294	$360.69	+$481.98M → PCOGF
3	$95,653,925,531	$95,138,198,928.81	$12,133	$476.91	+$95653.91M → PCOGF
4	$17,748,021,186,660	$17,645,671,486,342.04	$13,156	$635.42	+$17748021.17M → PCOGF
5	$3,078,850,357,047,340	$3,059,859,974,377,613.50	$14,432	$854.61	+$3078850357.03M → PCOGF
6	$499,379,737,853,365,100	$496,085,367,971,324,400.00	$16,056	$1,162.76	+$499379737853.35M → PCOGF
7	$75,733,840,285,631,510,000	$75,199,503,966,128,420,000.00	$18,175	$1,604.53	+$75733840285631.50M → PCOGF
8	$10,739,392,155,954,406,000,000	$10,658,356,946,848,782,000,000.00	$21,009	$2,252.68	+$10739392155954406.00M → PCOGF
9	$1,424,016,350,117,565,000,000,000	$1,412,525,200,510,693,700,000,000.00	$24,911	$3,229.73	+$1424016350117564928.00M → PCOGF
10	$176,567,887,962,527,560,000,000,000	$175,044,190,467,901,770,000,000,000.00	$30,458	$4,749.88	+$176567887962527563776.00M → PCOGF

PCOGF vs JNJ: Complete Analysis 2026

PCOGF — Stock

Pancontinental Energy NL explores for oil and gas properties in Australia, Namibia, and Kenya. The company holds interests in the PEL 37 project in Walvis Basin and the PEL 87 project in Orange Basin located in offshore Namibia; the Meeba project and Cooper Eromanga Basin located in Queensland, Australia; and the Amu Basin L6 located in Kenya. The company was formerly known as Pancontinental Oil & Gas NL and changed its name to Pancontinental Energy NL in September 2021. Pancontinental Energy NL was incorporated in 1985 and is based in West Perth, Australia.

Full PCOGF Calculator →

JNJ — Healthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →

📬

Get this PCOGF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PCOGF vs SCHD PCOGF vs JEPI PCOGF vs O PCOGF vs KO PCOGF vs MAIN PCOGF vs ABBV PCOGF vs MRK PCOGF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.